Tejasav S. Sehrawat

Tejasav S. Sehrawat

Auto-generated profile, based on publicly available information

Tejasav S. Sehrawat

Division of Gastroenterology and Hepatology,Mayo Clinic,Rochester,MN

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2021 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
ANAni Nalbandian
Ani Nalbandian
KSKartik Sehgal
Kartik Sehgal
AGAakriti Gupta
Aakriti Gupta
MMMahesh V. Madhavan
Mahesh V. Madhavan
CMClaire McGroder
Claire McGroder
EWElaine Y. Wan
Elaine Y. Wan

10 July 2020 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
AGAakriti Gupta
Aakriti Gupta
MMMahesh V. Madhavan
Mahesh V. Madhavan
KSKartik Sehgal
Kartik Sehgal
NNNandini Nair
Nandini Nair
SMShiwani Mahajan
Shiwani Mahajan
DLDonald W. Landry
Donald W. Landry

1 July 2019 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
MHMoira B. Hilscher
Moira B. Hilscher
TSTejasav Sehrawat
Tejasav Sehrawat
JAJuan P. Arab
Juan P. Arab
ZZZhutian Zeng
Zhutian Zeng
JGJinhang Gao
Jinhang Gao
VSVijay H. Shah
Vijay H. Shah

27 April 2020 in Hepatology
Verified
Journal Article
Closed access
JAJuan Pablo Arab
Juan Pablo Arab
TSTejasav S. Sehrawat
Tejasav S. Sehrawat
DSDouglas A. Simonetto
Douglas A. Simonetto
VVVikas K. Verma
Vikas K. Verma
DFDechun Feng
Dechun Feng
VSVijay H. Shah
Vijay H. Shah

17 July 2020 in Gastroenterology
Verified
Journal Article
Closed access
JBJasmohan Bajaj
Jasmohan Bajaj
KRK. Rajender Reddy
K. Rajender Reddy
JOJacqueline G. O’leary
Jacqueline G. O’leary
HVHugo E. Vargas
Hugo E. Vargas
JLJennifer C. Lai
Jennifer C. Lai
PGPatrick M. Gillevet
Patrick M. Gillevet

27 July 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
MLMengfei Liu
Mengfei Liu
SCSheng Cao
Sheng Cao
LHLi He
Li He
JGJinhang Gao
Jinhang Gao
JAJuan Pablo Arab
Juan Pablo Arab
VSVijay H. Shah
Vijay H. Shah
Alcoholic hepatitis (AH) is associated with liver neutrophil infiltration through activated cytokine pathways leading to elevated chemokine expression. Super-enhancers are expansive regulatory elements driving augmented gene expression. Here, we explore the mechanistic role of super-enhancers linking cytokine TNFα with chemokine amplification in AH. RNA-seq and histone modification ChIP-seq of human liver explants show upregulation of multiple CXCL chemokines in AH. Liver sinusoidal endothelial cells (LSEC) are identified as an important source of CXCL expression in human liver, regulated by TNFα/NF-κB signaling. A super-enhancer is identified for multiple CXCL genes by multiple approaches. dCas9-KRAB-mediated epigenome editing or pharmacologic inhibition of Bromodomain and Extraterminal (BET) proteins, transcriptional regulators vital to super-enhancer function, decreases chemokine expression in vitro and decreases neutrophil infiltration in murine models of AH. Our findings highlight the role of super-enhancer in propagating inflammatory signaling by inducing chemokine expression and the therapeutic potential of BET inhibition in AH treatment.